Bioluminescence measurement significantly improved the accuracy, sensitivity, precision, and reliability of the current visual endpoint determination for the USP sterility test and eliminated the day 7 transfer/dilution step required for testing suspension products. Thirteen strains of bacteria and fungi (representing potential contaminants in sterile products), three pharmaceutical suspensiori products, and four media were used in the experiment. No interference from suspension products was encountered in the detection of microbial growth by the bioluminescence measurement. The poor fungal growth encountered was attributed to insufficient diffusion of oxygen into the medium and was circumvented by use of a large tube size (38 by 200 mm) or by vortexing the medium once during the 2-week incubation period. Bioluminescence measurement would facilitate automated handling of the sterility test endpoint readout operation. The optimum parameters of bioluminescence measurement for application in sterility testing were determined.
The firefly luciferin-luciferase bioluminescence measurement for detection of ATP has been used for the qualitative and quantitative determination of microbial content in fluids and solids (1, 3, 5-6, 7, 9-11, 14, 15) . Applications have included clinical screening for bacteriuria in urine and blood (1, 3, 7, 11, 15) , antibiotic susceptibility testing (9, 10) , microbiological potency assays of antibiotics and vitamins (9, 10) , and determination of biomass in environmental samples (e.g., water, soil), foods, and beverages (9, 10, 14) . The purpose of this paper was not to shorten the incubation time of the sterility test required by the U.S. Pharmacopeia (16) but to provide objectivity to the visual endpoint readout operation currently in use and to eliminate the timeconsuming day 7 transfer/dilution operation, which is a potential contamination source, for testing pharmaceutical suspension products.
MATERIALS AND METHODS
Reagents. (i) Bioluminescence. The Firelight ATP test kit from Analytical Luminescence Laboratories (San Diego, Calif.) was used to perform the bioluminescence measurement. The reagents were stored in a refrigerator (4°C) and allowed to reach room temperature before use. The test kit included HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer (pH 7.75), Extralight ATP releasing reagent, Firelight luciferin-luciferase, and an ATP standard. Reagents were prepared fresh each day according to the manufacturer's instructions. The ATP stock standard solution was prepared by addition of 1.0 ml of sterile water-for-injection (WFI; The Upjohn Co., Kalamazoo, Mich.) per ATP standard vial to provide 2 x 10-8 M ATP. ATP working standard solution was freshly prepared each day by diluting the ATP stock solution. To determine day-to-day assay variation, several vials containing ATP stock solution were combined and frozen until used.
(ii) Media 
RESULTS AND DISCUSSION
Optimization of bioluminescence assay. ATP standard curves were constructed using the peak and the integration modes. Although the peak mode gave better precision (relative standard deviation [RSD], ca. 5 to 8%), the integration mode (RSD, ca. 4 to 15%) was chosen because of its superior sensitivity (10-14 M ATP) over the peak mode (10-13 M ATP).
(i) Integration time. An integration time of 10 s was selected from a choice of 10, 30, or 60 s because of lower background bioluminescence, superior linearity (r = 0.9992), sensitivity (10-11 to 10-14 M ATP), and shorter assay time.
(ii) Precision sensitivity. Results of ATP standard curves performed with 25-and 100-pdl samples indicated that the 100-,ul volume provided slightly better sensitivity (2 x 10-14 M ATP) than did 25 RI (5 x 10-14 M ATP). The linearity of the two standard curves was comparable, and the number of replicates (either three or four) had no significant effect (P < 0.001) on the linear regression parameters of either standard curve. However, the sample volume exhibited a profound influence on the RSD of the assay. An RSD of 14.5% obtained with the 25-pd sample size was reduced to 6.5% when the 100-pd sample volume was used.
The reproducibility of the bioluminescence measurement was evaluated by constructing ATP standard curves on 3 consecutive days. All reagents and ATP standards were prepared fresh each day. No significant difference (P < 0.002) in the slope, linearity, or RSD of the standard curves assayed on 3 separate days was observed. Therefore, the ATP bioluminescence assay method can reproducibly (RSD, 10 to 12%) detect ATP from 2 x 10-11 M to 2 x 10-14 M (r = 0.998).
(iii) Stability of reagent. The stability of the luciferinluciferase reagent was examined. The results indicated that the reagent is stable for at least 6.5 h at room temperature, since no significant difference (P < 0.002) existed between standard curves constructed at 15 min, 3.5 h, and 6.5 h after reconstitution. However, when the reconstituted reagent was stored overnight in a refrigerator, the sensitivity and linearity of the standard curve were reduced by approximately 50%. When the reagent was stored frozen, the background (blank) luminescence increased and the linear range and sensitivity of the assay were significantly decreased. Thus, the luciferin-luciferase reagent must be freshly prepared and used each day.
Detection of microorganisms. (i) Extraction/release of ATP. The ATP must be extracted/released from the microorganisms for detection by the bioluminescence assay. A perchloric acid method (2) was initially used to release the ATP from the cells. However, this procedure was tedious and time-consuming and resulted in low recovery of ATP from microorganisms. An ATP releasing reagent, Extralight, available from Analytical Luminescence Laboratories was evaluated for each of the 13 strains of microorganisms used in the study. The Extralight required at least 5 to 10 min of contact to achieve maximum extraction of ATP from approximately 75% of the microorganisms (Table 1 ). For P. cepacia and A. niger, the quantity of ATP did not significantly increase with increased extraction time; however, the bioluminescence remained stable for 15 min. Based on these results, an extraction time of 7 min was chosen for release of ATP from microbial cells to shorten the assay time.
(ii) Detection sensitivity. Various concentrations of S. epidermidis (UC 719), E. coli (UC 3114), C. albicans (UC 7275), and A. niger (UC 7048) were tested for bioluminescence. The linear range covered a 3-log concentration of microorganisms with correlation coefficients of 0.990 to 0.999 (Fig. 1) . The precision of the assay (RSD, ca. 2.5 to 10%) for the majority of the microorganisms was equivalent to or better than that of the ATP standard solution (RSD, ca. 10 to 12%). The higher RSD (-16%) for S. epidermidis may be due to the characteristic clumping of the microorganism.
The sensitivity of the bioluminescence assay for the detection of microorganisms is dependent on the ATP content per CFU and the species, age, and growth conditions of the microorganisms (e.g., medium, temperature) (5). As little as 104 CFU of S. epidermidis and E. coli per ml could be detected by the bioluminescence method, whereas ca. 102 CFU/ml was required to detect C. albicans and A. niger (Fig. 1) . In contrast, visual detection of turbidity, the current endpoint detection operation for the sterility test, requires at least 106 CFU/ml in a clear solution.
Effect of medium. Although the precision of the assay was not significantly affected, the medium increased the background (blank) bioluminescence. When the medium was diluted 1:10 and 1:100, the background bioluminescence was reduced by 72 and 90%, respectively. To ascertain that increased background levels were attributable to components in the medium which absorb at the wavelength (560 
nm) used for the bioluminescence assay, a Cary spectrophotometer was utilized to measure the absorbance for TSB and unoxidized Thio. The data indicated that the absorbance readings of TSB and Thio were significantly higher than that of the WFI blank but were reduced by dilution in WFI. Since aeration significantly contributes to the high background readings for Thio (optical density of 0.10 and 0.26 for unoxidized and oxidized Thio, respectively), resazurin, a redox indicator in Thio, may be the compound causing the interference in the oxidized Thio. TSB inhibited bioluminescence by about 50 to 60%. To identify the source of interference in TSB, components in the medium were individually tested for their inhibitory effect on bioluminescence. The cause of interference was traced to the NaCl (86 mM) present in the medium. NaCl concentrations between 20 and 200 mM have been reported to markedly reduce light emission from ATP standards (8) . Various ions, particularly chloride, have been identified as the primary source of bioluminescence interference in bacteriuria assays (8, 12, 13) . Dilution of the medium eliminated the interference without an equivalent loss in sensitivity of the bioluminescence measurement, since the increase in light output with decreasing inhibitor concentration was exponential, whereas the reduction in light output with decreasing ATP concentration was linear (12, 13) . The thioglycolate in Thio caused no effect on the bioluminescence assay.
TSB-N and Thio-N inhibited bioluminescence by 20 to 25%. Azolectin was identified as the cause of interference. Dilution of the medium effectively eliminated the interference. Tween-80 had no effect on bioluminescence.
Suspension products testing. The effects of the suspension products on bioluminescence were investigated for each of the three pharmaceutical products. The bioluminescence results in the presence of the suspension products were not significantly different from those of the ATP reference solution; the relative light units of the samples with Cortef, Medrol, and Provera were 107, 103, and 102%, respectively, of those without the products. Results of the bioluminescence measurements for 13 strains of bacteria and fungi in four media and three suspension products are shown in Table 2 . Since the media tested immediately after inoculation with less than 100 CFU of microorganisms per tube provided bioluminescence readings equivalent to those of the negative controls, any significant bioluminescence detected in samples assayed on day 3 and beyond can be attributed to the growth of the microorganism and not to a 'carry-over' effect from the inoculum. To confirm growth/ no growth in the turbid suspensions, the samples were streaked onto agar plates to substantiate the bioluminescence data.
For eight microorganisms, B. subtilis, S. epidermidis, E. coli, Corynebacteriium sp., P. aeriuginosa, P. cepacia, S. pyogenes, and C. sporogenes, the bioluminescence measurement had no problem in detecting the growth of the microorganisms in the presence of the suspension products (Table 2) . Bioluminescence was detected in 100% (four of four) of the tubes tested on each of the three test dates (days 3, 7, and 14) during the 2 weeks of incubation. An exception was E. coli in Thio or Thio-N: although significant bioluminescence readings were recorded on days 3 and 7, the culture lysed by day 14 and no bioluminescence was detected. Streak plates verified the loss of viable cells in the samples. In contrast, E. coli in TSB or TSB-N did not lyse and was detected from day 3 to the end of the 2-week incubation period (Table 2) . Thus, this finding does not indicate a potential false-negative problem in the bioluminescence measurement, but rather underscores the reason for using the two types of compendially required media in sterility testing. Based on the visual examination of positive controls (without product), pink-pigmented bacteria and Microc'occuls sp. proved to be slow growers, especially in TSB (Table 2) . Although the visual indication of growth was still questionable by day 14, bioluminescence measurement detected microbial growth in over 60% of the positive controls on day 7 and in 75 to 100% of the tubes on day 14. Some products did inhibit the growth of certain microorganisms in some media: Micrococcus sp. in TSB with Depo-Provera Sterile Aqueous Suspension; Corynebacterium sp. and pink-pigmented bacterium in Thio with Cortef Sterile Aqueous Suspension; C. albicans in Thio with DepoProvera Sterile Aqueous Suspension; and C. albicans in Thio-N with Depo-Medrol Sterile Aqueous Suspension (Table 2). The lack of growth was verified by the streak plates. In all cases, the growth of these five microorganisms was facilitated by one of the other types of medium (TSB or Thio) in the presence of the products ( Table 2) .
The results of the study described above indicate that the bioluminescence measurement is sensitive for the detection of microorganisms without interference from suspension products and provides objectivity to the visual endpoint readout operation currently in use for the sterility test.
Growth of fungi and mold. It was noted from visual 7 .500 Ta  3  7 observations of the positive controls that the cultural conditions for the growth of Penicillium sp. and A. niger in TSB might not be optimum (Table 2 ). Since TSB was prepared and sterilized in tubes 25 by 200 mm in size, the surface area-to-volume ratio may have been unfavorable, causing insufficient diffusion of oxygen into the medium and thereby limiting the growth of fungi. When TSB was prepared in larger tubes (38 by 200 mm), the growth of C. albicans and A. niger was detected in 100% of the samples tested on all testing days (3, 7, and 14 days), and no product interference was noted (Table 3) . Similarly, Penicillium sp. was able to grow and be detected, without product interference, in all samples tested on day 7 ( Table 3) .
The results described above clearly indicated that the growth of fungi in TSB and TSB-N was enhanced by preparing the medium (40 ml per tube) in a larger tube (38 by 200 mm) to increase the surface area-to-volume ratio, thereby enhancing the diffusion of oxygen into the medium. The oxygen content in TSB prepared in the larger tube (38 by 200 mm) exhibited a higher level on day 1 and rapidly reached the maximum, equilibrium concentration of 6.8 to 7.0 ppm by day 5 to 7 ( Fig. 2) . In contrast, the oxygen content in the medium placed in the smaller container (25 by 200 mm) slowly increased and reached the maximum oxygen concentration of 7.0 ppm after 13 to 15 days. These results compared favorably with the theoretical oxygen level calculated in each of two container sizes using the following equation (4) where C is oxygen concentration achieved, fraction of the equilibrium; I is depth of medium (5.0 cm for large tube and 10.8 cm for small tube); t is time after autoclaving (days); n is the point of 02 measurement, yll (1/4 from the top of the medium); t is dimensionless time, at/I2; and a is diffusivity of oxygen in aqueous solution (X l0-5 cm2/s). Use of an aged, oxygen-saturated medium in the smaller tube (14-day-old medium gave 14 positives out of 20) or vortexing once during the 2-week incubation period to increase dissolved oxygen level (10 positives out of 10) also improved fungal growth.
Elimination of day 7 transfer/dilution requirement. The primary purpose of the day 7 transfer, used for sterility testing of suspension products, is to minimize by dilution the turbidity created by suspension products or medium and thereby permit the visual endpoint determination of microbial growth. However, the transfer operation might also serve to promote microbial growth by minimizing product interference via dilution. However, samples which were negative by bioluminescence on day 7 failed to grow upon transfer into fresh medium (Table 4 ). In addition, approximately 25 to 50% of the samples transferred from the tubes with positive bioluminescence results on day 7 failed to show growth (visually and by bioluminescence) after incubation for 7 additional days. This may be due to nonhomogeneous distribution of microorganisms in the medium on day 7, and a 0.5-ml sample size used for transfer may not have represented the sample. Thus, the transfer/dilution operation would not alleviate the problem, but would rather increase the potential for false-negative and false-positive (laboratory contamination) results. Since the bioluminescence measurement is sensitive enough to detect 103 to 104 CFU/ml in turbid suspension samples, this measurement effectively eliminates the need of the day 7 transfer/dilution operation and thereby minimizes potential assay problems, provides manpower savings, and facilitates automated handling of the endpoint readout operation.
